Table II.
Intracellular localization of galectin-1, -3, -4, -7, -8 and -9.a
| Galectin-3 localization | Galectin-3 localization | Galectin-4 localization | Galectin-7 localization | Galectin-8 localization | Galectin-9 localization | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|||||||||||||
| Type of tissue | C n/total (%) |
N n/total (%) |
C + N n/total (%) |
C n/total (%) |
N n/total (%) |
C + N n/total (%) |
C n/total (%) |
N n/total (%) |
C + N n/total (%) |
C n/total (%) |
N n/total (%) |
C + N n/total (%) |
C n/total (%) |
N n/total (%) |
C + N n/total (%) |
C n/total (%) |
N n/total (%) |
C + N n/total (%) |
| Non-eosinophilic chronic rhinosinusitis (n=10) | 0/10 (0) | 0/10 (0) | 10/10 (100) | 0/10 (0) | 0/10 (0) | 10/10 (100) | 2/10 (20) | 0/10 (0) | 8/10 (80) | 0/10 (0) | 0/10 (0) | 10/10 (100) | 0/10 (0) | 0/10 (0) | 10/10 (100) | 2/10 (20) | 0/10 (0) | 8/10 (80) |
| Eosinophilic chronic rhinosinusitis (n=19) | 0/19 (0) | 0/19 (0) | 19/19 (100) | 0/19 (0) | 0/19 (0) | 19/19 (100) | 2/17 (12) | 0/17 (0) | 15/17 (88) | 0/19 (0) | 0/19 (0) | 19/19 (100) | 0/17 (0) | 0/17 (0) | 17/17 (100) | 11/17 (65) | 0/17 (0) | 6/17 (35) |
| Non-allergic nasal polyps (n=9) | 2/8 (25) | 0/8 (0) | 6/8 (75) | 0/9 (0) | 0/9 (0) | 9/9 (100) | 0/5 (0) | 0/5 (0) | 5/5 (100) | 0/9 (0) | 0/9 (0) | 9/9 (100) | 0/9 (0) | 0/9 (0) | 9/9 (100) | 0/8 (0) | 0/8 (0) | 8/8 (100) |
| Allergic nasal polyps (n=17) | 2/17 (12) | 0/17 (0) | 15/17 (88) | 0/17 (0) | 0/17 (0) | 17/17 (100) | 5/15 (33) | 0/15 (0) | 10/15 (67) | 0/17 (0) | 0/17 (0) | 17/17 (100) | 2/16 (12) | 0/16 (0) | 14/16 (88) | 3/16 (19) | 0/16 (0) | 13/16 (81) |
| Inverted papillomas (n=29) | 2/28 (7) | 0/28 (0) | 26/28 (93) | 1/24 (4) | 0/24 (0) | 23/24 (96) | 18/27 (67) | 0/27 (0) | 9/27 (33) | 0/27 (0) | 0/27 (0) | 27/27 (100) | 4/27 (15) | 0/27 (0) | 23/27 (85) | 6/27 (22) | 2/27 (8) | 19/27 (70) |
| Squamous cell carcinomas (n=6) | 6/6 (100) | 0/6 (0) | 0/6 (0) | 5/6 (83) | 0/6 (0) | 1/6 (16) | 2/6 (33) | 0/6 (0) | 4/6 (67) | 2/6 (33) | 0/6 (0) | 4/6 (67) | 2/5 (40) | 0/5 (0) | 3/5 (60) | 6/6 (100) | 0/6 (0) | 0/6 (0) |
a
Separated into cytoplasmic (C) and/or nuclear (N) signals. The number of cases and the percentage of immunopositive cases relative to the intracellular localization (in parentheses) are provided for each type of tissue.